{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:21:51Z","timestamp":1760296911026},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1053\/beha.2002.0231","type":"journal-article","created":{"date-parts":[[2003,3,4]],"date-time":"2003-03-04T18:13:53Z","timestamp":1046801633000},"page":"695-711","source":"Crossref","is-referenced-by-count":27,"title":["Treatment of mature B-ALL and high grade B-NHL in children"],"prefix":"10.1053","volume":"15","author":[{"given":"Catherine","family":"Patte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/beha.2002.0231_RF1","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1200\/JCO.2000.18.21.3707","article-title":"Molecular biology of Burkitt's lymphoma","volume":"18","author":"Hecht","year":"2000","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0231_RF2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00043426-199122000-00019","article-title":"African Burkitt's lymphoma. History, biology, clinical features, and treatment","volume":"13","author":"Magrath","year":"1991","journal-title":"American Journal of Pediatric Hematology and Oncology"},{"key":"10.1053\/beha.2002.0231_RF3","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJM199605093341906","article-title":"Non-Hodgkin's lymphoma in childhood","volume":"334","author":"Sandlund","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0231_RF4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0959-8049(97)10142-3","article-title":"Non-Hodgkin's lymphoma","volume":"34","author":"Patte","year":"1998","journal-title":"European Journal of Cancer"},{"key":"10.1053\/beha.2002.0231_RF5","first-page":"332","article-title":"Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults","volume":"7","author":"Murphy","year":"1980","journal-title":"Seminars in Oncology"},{"key":"10.1053\/beha.2002.0231_RF6","first-page":"81","article-title":"B-acute lymphoblastic leukaemia. The European experience","volume":"5","author":"Patte","year":"1998","journal-title":"International Journal of Pediatric Hematology\/Oncology"},{"key":"10.1053\/beha.2002.0231_RF7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1200\/JCO.2001.19.3.697","article-title":"Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma","volume":"19","author":"Pui","year":"2001","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0231_RF8","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/annonc\/mdf134","article-title":"Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Societe Francaise d'Oncologie Pediatrique LMB89 protocol","volume":"13","author":"Patte","year":"2002","journal-title":"Annals of Oncology"},{"key":"10.1053\/beha.2002.0231_RF9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1056\/NEJM198303103081003","article-title":"Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2)","volume":"308","author":"Anderson","year":"1983","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0231_RF10","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1200\/JCO.1986.4.8.1219","article-title":"Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society","volume":"4","author":"Patte","year":"1986","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0231_RF11","first-page":"397","article-title":"Updated results of the LMB86 protocol of the French Society of Pediatric Oncology (SFOP) for B-cell non Hodgkin's lymphoma with CNS involvement and B ALL","volume":"18","author":"Patte","year":"1990","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1053\/beha.2002.0231_RF12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1200\/JCO.1991.9.1.123","article-title":"High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children","volume":"9","author":"Patte","year":"1991","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0231_RF13","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1200\/JCO.1988.6.7.1118","article-title":"High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma","volume":"6","author":"Philip","year":"1988","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0231_RF14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1200\/JCO.1990.8.4.661","article-title":"Phase II study of cytarabine and etoposide in children with refractory or relapsed non-Hodgkin's lymphoma: a study of the French Society of Pediatric Oncology","volume":"8","author":"Gentet","year":"1990","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0231_RF15","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V97.11.3370","article-title":"The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia","volume":"97","author":"Patte","year":"2001","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0231_RF16","first-page":"135","article-title":"[BFM study 1981\/83 of the treatment of highly malignant non-Hodgkin's lymphoma in children: results of therapy stratified according to histologic immunological type and clinical stage]","volume":"196","author":"Muller-Weihrich","year":"1984","journal-title":"Klinic Padiatrics"},{"key":"10.1053\/beha.2002.0231_RF17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1200\/JCO.1995.13.2.359","article-title":"Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage\u2014a report of the Berlin\u2013Frankfurt\u2013Munster Group","volume":"13","author":"Reiter","year":"1995","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0231_RF18","first-page":"3294","article-title":"Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin\u2013Frankfurt\u2013Munster Group Trial NHL-BFM 90","volume":"94","author":"Reiter","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0231_RF19","first-page":"342a","article-title":"A 4h infusion of methotrexate 5g\/sqm is not as efficacious for treatment of advanced B-cell neoplasms of chidhood and adolescence than a 24h IV infusion although less toxic. Interim results of trial NHL-BFM 95","volume":"98","author":"Reiter","year":"2001","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0231_RF20","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1054\/bjoc.1999.1083","article-title":"Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol","volume":"82","author":"Atra","year":"2000","journal-title":"British Journal of Cancer"},{"key":"10.1053\/beha.2002.0231_RF21","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/bjc.1998.379","article-title":"Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL)\u2014results of the UKCCSG 9003 protocol","volume":"77","author":"Atra","year":"1998","journal-title":"British Journal of Cancer"},{"key":"10.1053\/beha.2002.0231_RF22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/(SICI)1096-911X(199712)29:6<526::AID-MPO2>3.0.CO;2-M","article-title":"Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group","volume":"29","author":"Brecher","year":"1997","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1053\/beha.2002.0231_RF23","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1200\/JCO.1996.14.4.1252","article-title":"Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study","volume":"14","author":"Bowman","year":"1996","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0231_RF24","article-title":"Successful treatment of small noncleaved cell lymphoma and B cell ALL with CNS involvement: a Pediatric Oncology Group (POG) study","volume":"19","author":"Schwenn","year":"2000","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0231_RF25","article-title":"The addition of VP-Ifosfamide did not improve EFS for CNS negative patients with advanced-stage small noncleaved lymphoma or B-cell ALL: a POG study","volume":"21","author":"Schwenn","year":"2001","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0231_RF26","first-page":"151","article-title":"B-cell acute lymphoblastic leukemia (B-ALL): a report of 17 pediatric cases","volume":"77","author":"Rosanda","year":"1992","journal-title":"Haematologica"},{"key":"10.1053\/beha.2002.0231_RF27","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/sj.leu.2402402","article-title":"Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate (\u2018Orange\u2019) in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report","volume":"16","author":"Cairo","year":"2002","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0231_RF28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/1096-911X(200007)35:1<8::AID-MPO2>3.0.CO;2-P","article-title":"Improved outcome in childhood B-cell lymphoma with the intensified French LMB protocol","volume":"35","author":"Yaniv","year":"2000","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1053\/beha.2002.0231_RF29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/088800199277254","article-title":"Treatment of pediatric B-cell non-Hodgkin's lymphomas at the Motol Hospital in Prague, Czech Republic: results based on the NHL BFM 90 protocols","volume":"16","author":"Kavan","year":"1999","journal-title":"Pediatric Hematology\/Oncology"},{"key":"10.1053\/beha.2002.0231_RF30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0925-5710(97)00579-3","article-title":"Treatment outcome of AT-B88 regimen for B-cell non-Hodgkin's lymphoma and surface immunoglobulin-positive acute lymphoblastic leukemia in children","volume":"66","author":"Horibe","year":"1997","journal-title":"International Journal of Hematology"},{"key":"10.1053\/beha.2002.0231_RF31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/(SICI)1096-911X(199705)28:5<333::AID-MPO2>3.0.CO;2-I","article-title":"Results of a BFM-based protocol for the treatment of childhood B-non-Hodgkin's lymphoma and B-acute lymphoblastic leukemia in Argentina","volume":"28","author":"Chantada","year":"1997","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1053\/beha.2002.0231_RF32","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","article-title":"Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen","volume":"14","author":"Magrath","year":"1996","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0231_RF33","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1200\/JCO.2002.08.088","article-title":"Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children","volume":"20","author":"Spreafico","year":"2002","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0231_RF34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/(SICI)1096-911X(200002)34:2<143::AID-MPO15>3.0.CO;2-1","article-title":"High-dose intense chemotherapy in South African children with B-cell lymphoma: morbidity, supportive measures, and outcome","volume":"34","author":"Hesseling","year":"2000","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1053\/beha.2002.0231_RF35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/(SICI)1096-911X(200002)34:2<142::AID-MPO14>3.0.CO;2-5","article-title":"The S.I.O.P. burkitt lymphoma pilot study in Malawi, Africa","volume":"34","author":"Hesseling","year":"2000","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1053\/beha.2002.0231_RF36","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/1097-0142(1967)20:5<756::AID-CNCR2820200530>3.0.CO;2-P","article-title":"Long-term remissions following one and two-dose chemotherapy for African lymphoma","volume":"20","author":"Burkitt","year":"1967","journal-title":"Cancer"},{"key":"10.1053\/beha.2002.0231_RF37","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/1097-0142(197609)38:3<1043::AID-CNCR2820380302>3.0.CO;2-U","article-title":"Methotrexate and citrovorum factor rescue in the management of childhood lymphosarcoma and reticulum cell sarcoma (non-Hodgkin's lymphomas): prolonged unmaintained remissions","volume":"38","author":"Djerassi","year":"1976","journal-title":"Cancer"},{"key":"10.1053\/beha.2002.0231_RF38","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/1097-0142(196608)19:8<1131::AID-CNCR2820190813>3.0.CO;2-I","article-title":"African lymphoma. Observations on response to vincristine sulphate therapy","volume":"19","author":"Burkitt","year":"1966","journal-title":"Cancer"},{"key":"10.1053\/beha.2002.0231_RF39","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/mpo.1226","article-title":"Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: a report from the Children's Cancer Group","volume":"37","author":"Sposto","year":"2001","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1053\/beha.2002.0231_RF40","first-page":"267","article-title":"Ifosfamide in the treatment of high-grade recurrent non-Hodgkin's lymphomas","volume":"9","author":"Magrath","year":"1991","journal-title":"Hematology\/Oncology"},{"key":"10.1053\/beha.2002.0231_RF41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/08880019009034320","article-title":"Cerebrospinal fluid and plasma methotrexate levels following high-dose regimen given as a 3-hour intravenous infusion in children with non Hodgkin's lymphoma","volume":"7","author":"Vassal","year":"1990","journal-title":"Pediatric Hematology\/Oncology"},{"key":"10.1053\/beha.2002.0231_RF42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/1097-0142(19930715)72:2<439::AID-CNCR2820720220>3.0.CO;2-4","article-title":"The role of systemic high-dose cytarabine in the treatment of central nervous system leukemia. Clinical results in 46 patients","volume":"72","author":"Morra","year":"1993","journal-title":"Cancer"},{"key":"10.1053\/beha.2002.0231_RF43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/10428199609067586","article-title":"Treatment of patients with high grade non-Hodgkin's lymphomas and central nervous system involvement: is radiation an essential component of therapy?","volume":"21","author":"Magrath","year":"1996","journal-title":"Leukemia and Lymphoma"},{"key":"10.1053\/beha.2002.0231_RF44","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1200\/JCO.1991.9.11.1973","article-title":"CNS involvement in small non-cleaved-cell lymphoma: is CNS disease per se a poor prognostic sign?","volume":"9","author":"Haddy","year":"1991","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0231_RF45","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1200\/JCO.2000.18.16.3018","article-title":"CNS involvement in children with newly diagnosed non-Hodgkin's lymphoma","volume":"18","author":"Sandlund","year":"2000","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0231_RF46","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1200\/JCO.2000.18.10.2017","article-title":"Outcome of CNS disease at diagnosis in disseminated small noncleaved-cell lymphoma and B-cell leukemia: a Children's Cancer Group study","volume":"18","author":"Gururangan","year":"2000","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0231_RF47","first-page":"147a","article-title":"CNS involvement in childhood malignancies: is it a bad prognostic factor per se? Experience of the SFOP LMB89 study","volume":"13","author":"Patte","year":"2002","journal-title":"Annals of Oncology"},{"key":"10.1053\/beha.2002.0231_RF48","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/sj.leu.2400850","article-title":"Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies","volume":"11","author":"Pui","year":"1997","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0231_RF49","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1182\/blood.V97.10.2998","article-title":"A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis","volume":"97","author":"Goldman","year":"2001","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0231_RF50","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.20.2.441","article-title":"Granulocyte colony-stimulating factor in induction treatment of children with non-Hodgkin's lymphoma: a randomized study of the French Society of Pediatric Oncology","volume":"20","author":"Patte","year":"2002","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0231_RF51","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1046\/j.1365-2141.2001.02647.x","article-title":"Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003\/9002 protocols","volume":"112","author":"Atra","year":"2001","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0231_RF52","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1182\/blood.V90.8.2921","article-title":"High-dose chemotherapy with autologous bone marrow rescue in children with poor-risk Burkitt's lymphoma: a report from the European Lymphoma Bone Marrow Transplantation Registry","volume":"90","author":"Ladenstein","year":"1997","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0231_RF53","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/1097-0142(197803)41:3<1059::AID-CNCR2820410339>3.0.CO;2-N","article-title":"Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse","volume":"41","author":"Appelbaum","year":"1978","journal-title":"Cancer"},{"key":"10.1053\/beha.2002.0231_RF54","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1200\/JCO.1984.2.9.979","article-title":"High-dose polychemotherapy with autologous bone marrow transplantation in children with relapsed lymphomas","volume":"2","author":"Hartmann","year":"1984","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0231_RF55","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood.V81.8.2003.2003","article-title":"Curability of relapsed childhood B-cell non-Hodgkin's lymphoma after intensive first line therapy: a report from the Societe Francaise d'Oncologie Pediatrique","volume":"81","author":"Philip","year":"1993","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0231_RF56","first-page":"465","article-title":"High-dose chemotherapy containing busulfan followed by bone marrow transplantation in 24 children with refractory or relapsed non-Hodgkin's lymphoma","volume":"8","author":"Loiseau","year":"1991","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0231_RF57","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00005176-200204000-00014","article-title":"Anti-CD20 monoclonal antibody (rituximab) treatment for Epstein\u2013Barr virus-associated B-cell lymphoproliferative disease in pediatric liver transplant recipients","volume":"34","author":"Serinet","year":"2002","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1053\/beha.2002.0231_RF58","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1046\/j.1365-2141.2001.03041.x","article-title":"Chimaeric anti-CD20 monoclonal antibody (rituximab) in post-transplant B-lymphoproliferative disorder following stem cell transplantation in children","volume":"115","author":"Faye","year":"2001","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0231_RF59","article-title":"Successful therapy in a child with relapsed B-ALL with anti CD20 antibodies","volume":"160","author":"Corbacioglu","year":"2001","journal-title":"European Journal of Pediatrics"},{"key":"10.1053\/beha.2002.0231_RF60","first-page":"269b","article-title":"Rituximab in the treatment of childhood B-ALL and Burkitt's lymphoma, report on 3 cases","volume":"94","author":"Veermann","year":"1999","journal-title":"Blood"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692602902318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692602902318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T19:49:24Z","timestamp":1584474564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692602902318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["S1521692602902318"],"URL":"https:\/\/doi.org\/10.1053\/beha.2002.0231","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}